The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
89BIO INC | COM | 282559103 | BBG00QKDZ8J5 | 114,002,369 | 8,955,410 | SH | SOLE | 8,955,410 | 0 | 0 | ||
AADI BIOSCIENCE INC | COM | 00032Q104 | BBG002WN7DT2 | 7,572,497 | 590,218 | SH | SOLE | 590,218 | 0 | 0 | ||
ACHILLES THERAPEUTICS PLC | SPONSORED ADS | 00449L102 | BBG00ZHF9VV8 | 1,447,051 | 1,607,834 | SH | SOLE | 1,607,834 | 0 | 0 | ||
ACLARIS THERAPEUTICS INC | COM | 00461U105 | BBG003LF0QR9 | 69,275,635 | 4,398,453 | SH | SOLE | 4,398,453 | 0 | 0 | ||
ACRIVON THERAPEUTICS INC | COMMON STOCK | 004890109 | BBG011RWR2Q4 | 55,417,052 | 4,810,508 | SH | SOLE | 4,810,508 | 0 | 0 | ||
ACUMEN PHARMACEUTICALS INC | COM | 00509G209 | BBG0058YJ317 | 52,762,174 | 9,770,773 | SH | SOLE | 9,770,773 | 0 | 0 | ||
AEROVATE THERAPEUTICS INC | COM | 008064107 | BBG00WGHZFH4 | 242,134,673 | 8,263,982 | SH | SOLE | 8,263,982 | 0 | 0 | ||
AKERO THERAPEUTICS INC | COM | 00973Y108 | BBG00L9211Y8 | 52,552,104 | 958,980 | SH | SOLE | 958,980 | 0 | 0 | ||
ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | BBG001J2LL66 | 32,320,655 | 4,397,368 | SH | SOLE | 4,397,368 | 0 | 0 | ||
AN2 THERAPEUTICS INC | COM | 037326105 | BBG00QYLYBK4 | 35,961,617 | 3,773,517 | SH | SOLE | 3,773,517 | 0 | 0 | ||
ARS PHARMACEUTICALS INC | COM | 82835W108 | BBG00FZQGXG3 | 25,672,553 | 3,009,678 | SH | SOLE | 3,009,678 | 0 | 0 | ||
ARYA SCIENCES ACQUISITN CORP | CLASS A ORD SHS | G31658100 | BBG011LN0VR4 | 10,090,000 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | BBG007R7VNC1 | 849,680,271 | 6,957,179 | SH | SOLE | 6,957,179 | 0 | 0 | ||
ATHIRA PHARMA INC | COM | 04746L104 | BBG00C77LX40 | 5,963,721 | 1,881,300 | SH | SOLE | 1,881,300 | 0 | 0 | ||
AVIDITY BIOSCIENCES INC | COM | 05370A108 | BBG00FQ7LXW1 | 121,036,087 | 5,454,533 | SH | SOLE | 5,454,533 | 0 | 0 | ||
BELLUS HEALTH INC NEW | COM NEW | 07987C204 | BBG000CKVYZ4 | 102,360,158 | 12,452,574 | SH | SOLE | 12,452,574 | 0 | 0 | ||
BIOGEN INC | COM | 09062X103 | BBG000C17X76 | 147,568,453 | 532,892 | SH | SOLE | 532,892 | 0 | 0 | ||
BLACK DIAMOND THERAPEUTICS I | COM | 09203E105 | BBG00MS4Y0W9 | 4,661,827 | 2,589,904 | SH | SOLE | 2,589,904 | 0 | 0 | ||
CELCUITY INC | COM | 15102K100 | BBG00HKBW045 | 19,614,014 | 1,400,001 | SH | SOLE | 1,400,001 | 0 | 0 | ||
CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | BBG000FW8LZ9 | 92,482,750 | 2,075,000 | SH | SOLE | 2,075,000 | 0 | 0 | ||
COGENT COMMUNICATIONS HLDGS | COM NEW | 19240Q201 | BBG007DHZQR7 | 69,354,000 | 5,999,481 | SH | SOLE | 5,999,481 | 0 | 0 | ||
CONCERT PHARMACEUTICALS INC | COM | 206022105 | BBG001RY41W1 | 6,355,649 | 1,088,296 | SH | SOLE | 1,088,296 | 0 | 0 | ||
CONNECT BIOPHARMA HLDGS LTD | ADS | 207523101 | BBG00ZGYNJ49 | 6,066,792 | 6,991,003 | SH | SOLE | 6,991,003 | 0 | 0 | ||
CVRX INC | COM | 126638105 | BBG001B56NX0 | 5,046,250 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | ||
CYTEK BIOSCIENCES INC | COM | 23285D109 | BBG00D36Q0Z7 | 136,620,561 | 13,381,054 | SH | SOLE | 13,381,054 | 0 | 0 | ||
DA32 LIFE SCNCE | CLASS A COM | 23312M106 | BBG011PFN2X9 | 14,992,500 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
DAY ONE BIOPHARMACEUTICALS I | COM | 23954D109 | BBG00V1KSN04 | 151,514,185 | 7,040,622 | SH | SOLE | 7,040,622 | 0 | 0 | ||
DBV TECHNOLOGIES S A | SPONSORED ADR | 23306J101 | BBG0076D3T39 | 2,997,204 | 1,958,957 | SH | SOLE | 1,958,957 | 0 | 0 | ||
DESIGN THERAPEUTICS INC | COM | 25056L103 | BBG00SNC49V8 | 30,484,830 | 2,971,231 | SH | SOLE | 2,971,231 | 0 | 0 | ||
DICE THERAPEUTICS INC | COM | 23345J104 | BBG00WLPGWQ4 | 213,686,023 | 6,848,911 | SH | SOLE | 6,848,911 | 0 | 0 | ||
ELIEM THERAPEUTICS INC | COM | 28658R106 | BBG00ZNKL0K6 | 48,263,616 | 13,150,849 | SH | SOLE | 13,150,849 | 0 | 0 | ||
ENTERA BIO LTD | SHS | M40527109 | BBG000R1K184 | 216,055 | 295,966 | SH | SOLE | 295,966 | 0 | 0 | ||
EYEPOINT PHARMACEUTICALS INC | COM NEW | 30233G209 | BBG000F90JX5 | 11,796,771 | 3,370,506 | SH | SOLE | 3,370,506 | 0 | 0 | ||
FULCRUM THERAPEUTICS INC | COM | 359616109 | BBG00DDY1RK9 | 69,203,134 | 9,505,925 | SH | SOLE | 9,505,925 | 0 | 0 | ||
FUSION PHARMACEUTICALS INC | COM | 36118A100 | BBG00V9VQ3R9 | 2,078,975 | 659,992 | SH | SOLE | 659,992 | 0 | 0 | ||
GERON CORP | COM | 374163103 | BBG000GX1891 | 31,292,321 | 12,930,711 | SH | SOLE | 12,930,711 | 0 | 0 | ||
GH RESEARCH PLC | ORDINARY SHARES | G3855L106 | BBG011BQC379 | 47,612,186 | 4,898,373 | SH | SOLE | 4,898,373 | 0 | 0 | ||
HEALTH SCIENCES ACQ CORP 2 | ORD SHS | G4411D109 | BBG00W5FR2T5 | 6,090,624 | 610,283 | SH | SOLE | 610,283 | 0 | 0 | ||
HILLEVAX INC | COM | 43157M102 | BBG012FCPWH5 | 29,445,118 | 1,760,019 | SH | SOLE | 1,760,019 | 0 | 0 | ||
ICOSAVAX INC | COM | 45114M109 | BBG00QHK2J87 | 47,350,706 | 5,963,565 | SH | SOLE | 5,963,565 | 0 | 0 | ||
IMARA INC | COM | 45249V107 | BBG00CP3BDD4 | 13,295,461 | 3,250,724 | SH | SOLE | 3,250,724 | 0 | 0 | ||
IMMUNIC INC | COM | 4525EP101 | BBG001M75SX4 | 885,058 | 632,184 | SH | SOLE | 632,184 | 0 | 0 | ||
IMMUNOGEN INC | COM | 45253H101 | BBG000C2JTB5 | 108,395,632 | 21,853,958 | SH | SOLE | 21,853,958 | 0 | 0 | ||
INHIBRX INC | COM | 45720L107 | BBG00P80N9T9 | 94,959,283 | 3,853,867 | SH | SOLE | 3,853,867 | 0 | 0 | ||
IO BIOTECH INC | COM | 449778109 | BBG0131XRY31 | 2,592,698 | 1,127,260 | SH | SOLE | 1,127,260 | 0 | 0 | ||
ITEOS THERAPEUTICS INC | COM | 46565G104 | BBG00VPNFSJ5 | 86,269,068 | 4,417,259 | SH | SOLE | 4,417,259 | 0 | 0 | ||
JANUX THERAPEUTICS INC | COM | 47103J105 | BBG00ZHSKH11 | 114,192,381 | 8,670,644 | SH | SOLE | 8,670,644 | 0 | 0 | ||
KINNATE BIOPHARMA INC | COM | 49705R105 | BBG00R4SGVG1 | 26,011,278 | 4,264,144 | SH | SOLE | 4,264,144 | 0 | 0 | ||
LEGEND BIOTECH CORP | SPONSORED ADS | 52490G102 | BBG00TTGH5W4 | 121,616,252 | 2,436,223 | SH | SOLE | 2,436,223 | 0 | 0 | ||
NANOSTRING TECHNOLOGIES | COM | 63009R109 | BBG0019K7GX4 | 1,146,883 | 143,900 | SH | SOLE | 143,900 | 0 | 0 | ||
NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | N62509109 | BBG01BNNTQN4 | 43,600,000 | 4,000,000 | SH | SOLE | 4,000,000 | 0 | 0 | ||
NKARTA INC | COM | 65487U108 | BBG00JXHS9G7 | 46,752,723 | 7,805,129 | SH | SOLE | 7,805,129 | 0 | 0 | ||
PEPGEN INC | COM | 713317105 | BBG012232618 | 108,724,198 | 8,131,952 | SH | SOLE | 8,131,952 | 0 | 0 | ||
RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | BBG007DLZ601 | 160,627,871 | 5,516,067 | SH | SOLE | 5,516,067 | 0 | 0 | ||
ROCKET PHARMACEUTICALS INC | COM | 77313F106 | BBG000WG3567 | 47,107,906 | 2,407,149 | SH | SOLE | 2,407,149 | 0 | 0 | ||
RXSIGHT INC | COM | 78349D107 | BBG00THX1YN4 | 38,678,925 | 3,052,796 | SH | SOLE | 3,052,796 | 0 | 0 | ||
SATSUMA PHARMACEUTICALS INC | COM | 80405P107 | BBG00FLQP542 | 5,322,827 | 5,914,252 | SH | SOLE | 5,914,252 | 0 | 0 | ||
SCPHARMACEUTICALS INC | COM | 810648105 | BBG00J24RT13 | 13,314,002 | 1,856,904 | SH | SOLE | 1,856,904 | 0 | 0 | ||
SOLID BIOSCIENCES INC | COM | 83422E204 | BBG00JN4FXG8 | 18,433,419 | 3,426,286 | SH | SOLE | 3,426,286 | 0 | 0 | ||
TENAYA THERAPEUTICS INC | COM | 87990A106 | BBG00FPMK2S3 | 12,195,641 | 6,067,483 | SH | SOLE | 6,067,483 | 0 | 0 | ||
THIRD HARMONIC BIO INC | COM | 88427A107 | BBG00Z14GXB0 | 2,299,154 | 534,687 | SH | SOLE | 534,687 | 0 | 0 | ||
TRAVERE THERAPEUTICS INC | COM | 89422G107 | BBG000P9D6W9 | 83,797,841 | 3,984,681 | SH | SOLE | 3,984,681 | 0 | 0 | ||
TYRA BIOSCIENCES INC | COM | 90240B106 | BBG00RCQD9D1 | 54,997,050 | 7,236,454 | SH | SOLE | 7,236,454 | 0 | 0 | ||
VAXCYTE INC | COM | 92243G108 | BBG009PHHPL8 | 280,865,159 | 5,857,459 | SH | SOLE | 5,857,459 | 0 | 0 | ||
VERONA PHARMA PLC | SPONSORED ADS | 925050106 | BBG00GD4KBL1 | 165,089,079 | 6,317,990 | SH | SOLE | 6,317,990 | 0 | 0 | ||
VIRIDIAN THERAPEUTICS INC | SPONSORED ADS | 92790C104 | BBG002H242Z5 | 25,704,800 | 880,000 | SH | SOLE | 880,000 | 0 | 0 | ||
VOR BIOPHARMA INC | COM | 929033108 | BBG00NBJRDT6 | 151,280,052 | 22,748,880 | SH | SOLE | 22,748,880 | 0 | 0 | ||
WAVE LIFE SCIENCES LTD | SHS | Y95308105 | BBG00B642V54 | 120,414,063 | 17,202,009 | SH | SOLE | 17,202,009 | 0 | 0 | ||
WEREWOLF THERAPEUTICS INC | COM | 95075A107 | BBG00QXQ9XK4 | 8,798,356 | 4,291,881 | SH | SOLE | 4,291,881 | 0 | 0 | ||
NEWAMSTERDAM PHARMA COMPANY | *W EXP 11/22/202 | N62509117 | BBG01BNP2MK0 | 289,433 | 333,333 | SH | SOLE | 333,333 | 0 | 0 |